Search Options Stock News and Analysis from Schaeffer's

Short Squeeze Stocks: The Usual Suspects, & One Newcomer

https://www.schaeffersresearch.com/content/analysis/2026/03/27/short-squeeze-stocks-the-usual-suspects-one-newcomer

3/27/2026 10:34 AM

The last thing investors are thinking about right now -- as Wall Street wrestles with surging oil prices -- is a short squeeze. But maybe that's what contrarians should be doing now, monitoring stocks...

Biotech Stocks Blasts Off After Eczema Drug Trial

https://www.schaeffersresearch.com/content/news/2025/06/24/biotech-stocks-blasts-off-after-eczema-drug-trial

6/24/2025 10:53 AM

Biotech stock Nektar Therapeutics Inc (NASDAQ:NKTR) is soaring today, up 83.7% at $17.52 at last glance, after the company's eczema drug, rezpegaldesleukin, met its primary and secondary goals in a ...

Nektar Therapeutics Pullback May Be Short-Lived

https://www.schaeffersresearch.com/content/analysis/2020/01/23/nektar-therapeutics-pullback-may-be-short-lived

1/23/2020 11:43 AM

Biopharmaceutical stock Nektar Therapeutics (NASDAQ:NKTR) is down 0.5% this afternoon, last seen at $22.02. NKTR has recently struggled to gain momentum, but earlier this month touched its highest in...

Nektar Therapeutics Options Pop as Stock Soars

https://www.schaeffersresearch.com/content/options/2020/01/10/nektar-therapeutics-options-pop-as-stock-soars

1/10/2020 1:34 PM

The shares of Nektar Therapeutics (NASDAQ:NKTR) are pacing for their biggest one-day jump in almost two years after the firm amended its collaboration agreement with Bristol-Myers Squibb (BMY). The t...

S&P 500 Addition Bolsters Struggling LVS Stock

https://www.schaeffersresearch.com/content/news/2019/09/27/s-p-500-addition-bolsters-struggling-lvs-stock

9/27/2019 9:35 AM

It was announced last night that casino name Las Vegas Sands Corp. (NYSE:LVS) will be joining the S&P 500 Index (SPX), replacing Nektar Therapeutics (NKTR), which is headed to the S&P MidCap 400 Inde...

PEOPLE ALSO SEARCH FOR